John Alam, M.D.

EIP Pharma, Inc.

Contact Information

John Alam, M.D.
Boston

Professional Information

President and CEO
EIP Pharma, Inc.

Education

S.B. in chemical engineering from the Massachusetts Institute of Technology. M.D. from Northwestern University School of Medicine. Internal medicine residency at Brigham and Women’s Hospital. Post-doctoral fellowship at Dana-Farber Cancer Institute (David Livingston lab).

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:

Co-founder and CEO of, and equity holder in EIP Pharma Inc., a private corporate entity that is developing a small molecule kinase inhibitor (neflamapimod, p38alpha kinase inhibitor) as a treatment for neurodegenerative diseases.